Health-care companies ticked down amid doubts about the regulatory outlook.
President Joe Biden's budget proposal vows to cut drug prices for Americans.
Shares of Lexicon Pharmaceuticals rose after the company reported a narrower-than-expected loss for the fourth quarter and provided an update on its sotagliflozin.
Biotech stock MoonLake Immunotherapeutics rallied after the company said its experimental psoriatic arthritis treatment beat out AbbVie's Humira in a 24-week study.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-11-24 1658ET
